Caffeine Citrate

Vascular Headaches, Indigestion, Toothache + 20 more
Treatment
12 FDA approvals
20 Active Studies for Caffeine Citrate

What is Caffeine Citrate

CaffeineThe Generic name of this drug
Treatment SummaryCaffeine is a drug used to treat several conditions, such as respiratory issues in premature babies, pain relief, and drowsiness. It is found naturally in coffee beans, teas, and cacao beans. It is sometimes used in cosmetic products and can be taken orally, by inhalation, or by injection. Caffeine citrate injection is approved by the FDA and is used to treat apnea of the premature newborn. It is helpful in preventing and treating apnea and bronchopulmonary dysplasia in premature infants, which can lead to asthma and early onset emphysema.
Cafergotis the brand name
image of different drug pills on a surface
Caffeine Citrate Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Cafergot
Caffeine
1953
390

Approved as Treatment by the FDA

Caffeine, also called Cafergot, is approved by the FDA for 12 uses including Drug Overdose and central nervous system depression .
Drug Overdose
central nervous system depression
Tension Headache
Used to treat Tension Headache in combination with Acetylsalicylic acid
Respiratory Insufficiency
Chronic Fatigue Syndrome
Vascular Headaches
Used to treat Vascular Headaches in combination with Ergotamine
Fatigue
Pain
Used to treat Pain in combination with Acetaminophen
Mental Depression
Pain
Used to treat moderate Pain in combination with Acetaminophen
Chronic Pain
Used to treat Pain in combination with Acetaminophen
Tension-Type Headache
Used to treat Tension Headache in combination with Acetylsalicylic acid

Effectiveness

How Caffeine Citrate Affects PatientsCaffeine can make people feel more alert and active, but can also lead to feeling jittery and restless. Caffeine also helps to relax certain muscles, make the heart beat faster, and can improve athletic performance. It can also increase stomach acid and help with digestion, as well as help relieve migraine and other types of headaches when combined with other medications. Lastly, caffeine acts as a mild diuretic.
How Caffeine Citrate works in the bodyCaffeine affects many body systems in various ways. It can reduce drowsiness by blocking adenosine receptors in the brain, and can have a diuretic effect by increasing sodium excretion in the kidneys. In the heart, caffeine can increase heart rate and blood pressure, while also widening blood vessels. This helps to relieve migraines and headaches, which are often caused by narrowed vessels in the brain. Caffeine also has other effects on cells, but the clinical relevance of these is not well understood.

When to interrupt dosage

The quantity of Caffeine Citrate is contingent upon the diagnosed condition, including Overdose, Drug, Catarrh and Athletic Performance. The amount also changes as per the technique of delivery (e.g. Tablet or Tablet - Oral) presented in the table beneath.
Condition
Dosage
Administration
Catarrh
65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL
, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer - Oral, Tablet, multilayer, Solution, Solution - Intravenous, Solution - Oral, Syrup, Syrup - Oral, Powder, Powder - Oral, Liquid - Oral, Cream, Topical, Cream - Topical, Liquid, Capsule, coated, Capsule, coated - Oral, Granule - Oral, Granule, Tablet, effervescent, Tablet, effervescent - Oral, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Kit, Lozenge, Lozenge - Oral, Powder - Topical, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Ophthalmic; Oral; Topical, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical
Pain relief
65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL
, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer - Oral, Tablet, multilayer, Solution, Solution - Intravenous, Solution - Oral, Syrup, Syrup - Oral, Powder, Powder - Oral, Liquid - Oral, Cream, Topical, Cream - Topical, Liquid, Capsule, coated, Capsule, coated - Oral, Granule - Oral, Granule, Tablet, effervescent, Tablet, effervescent - Oral, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Kit, Lozenge, Lozenge - Oral, Powder - Topical, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Ophthalmic; Oral; Topical, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical
Eye
65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL
, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer - Oral, Tablet, multilayer, Solution, Solution - Intravenous, Solution - Oral, Syrup, Syrup - Oral, Powder, Powder - Oral, Liquid - Oral, Cream, Topical, Cream - Topical, Liquid, Capsule, coated, Capsule, coated - Oral, Granule - Oral, Granule, Tablet, effervescent, Tablet, effervescent - Oral, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Kit, Lozenge, Lozenge - Oral, Powder - Topical, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Ophthalmic; Oral; Topical, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical
Tension-Type Headache
65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL
, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer - Oral, Tablet, multilayer, Solution, Solution - Intravenous, Solution - Oral, Syrup, Syrup - Oral, Powder, Powder - Oral, Liquid - Oral, Cream, Topical, Cream - Topical, Liquid, Capsule, coated, Capsule, coated - Oral, Granule - Oral, Granule, Tablet, effervescent, Tablet, effervescent - Oral, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Kit, Lozenge, Lozenge - Oral, Powder - Topical, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Ophthalmic; Oral; Topical, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical
Acute Pain
65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL
, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer - Oral, Tablet, multilayer, Solution, Solution - Intravenous, Solution - Oral, Syrup, Syrup - Oral, Powder, Powder - Oral, Liquid - Oral, Cream, Topical, Cream - Topical, Liquid, Capsule, coated, Capsule, coated - Oral, Granule - Oral, Granule, Tablet, effervescent, Tablet, effervescent - Oral, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Kit, Lozenge, Lozenge - Oral, Powder - Topical, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Ophthalmic; Oral; Topical, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical
Toothache
65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL
, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer - Oral, Tablet, multilayer, Solution, Solution - Intravenous, Solution - Oral, Syrup, Syrup - Oral, Powder, Powder - Oral, Liquid - Oral, Cream, Topical, Cream - Topical, Liquid, Capsule, coated, Capsule, coated - Oral, Granule - Oral, Granule, Tablet, effervescent, Tablet, effervescent - Oral, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Kit, Lozenge, Lozenge - Oral, Powder - Topical, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Ophthalmic; Oral; Topical, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical
Pain
65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL
, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer - Oral, Tablet, multilayer, Solution, Solution - Intravenous, Solution - Oral, Syrup, Syrup - Oral, Powder, Powder - Oral, Liquid - Oral, Cream, Topical, Cream - Topical, Liquid, Capsule, coated, Capsule, coated - Oral, Granule - Oral, Granule, Tablet, effervescent, Tablet, effervescent - Oral, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Kit, Lozenge, Lozenge - Oral, Powder - Topical, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Ophthalmic; Oral; Topical, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical
Pain management
65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL
, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer - Oral, Tablet, multilayer, Solution, Solution - Intravenous, Solution - Oral, Syrup, Syrup - Oral, Powder, Powder - Oral, Liquid - Oral, Cream, Topical, Cream - Topical, Liquid, Capsule, coated, Capsule, coated - Oral, Granule - Oral, Granule, Tablet, effervescent, Tablet, effervescent - Oral, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Kit, Lozenge, Lozenge - Oral, Powder - Topical, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Ophthalmic; Oral; Topical, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical
Athletic Performance
65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL
, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer - Oral, Tablet, multilayer, Solution, Solution - Intravenous, Solution - Oral, Syrup, Syrup - Oral, Powder, Powder - Oral, Liquid - Oral, Cream, Topical, Cream - Topical, Liquid, Capsule, coated, Capsule, coated - Oral, Granule - Oral, Granule, Tablet, effervescent, Tablet, effervescent - Oral, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Kit, Lozenge, Lozenge - Oral, Powder - Topical, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Ophthalmic; Oral; Topical, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical
Vascular Headaches
65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL
, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer - Oral, Tablet, multilayer, Solution, Solution - Intravenous, Solution - Oral, Syrup, Syrup - Oral, Powder, Powder - Oral, Liquid - Oral, Cream, Topical, Cream - Topical, Liquid, Capsule, coated, Capsule, coated - Oral, Granule - Oral, Granule, Tablet, effervescent, Tablet, effervescent - Oral, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Kit, Lozenge, Lozenge - Oral, Powder - Topical, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Ophthalmic; Oral; Topical, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical
Indigestion
65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL
, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer - Oral, Tablet, multilayer, Solution, Solution - Intravenous, Solution - Oral, Syrup, Syrup - Oral, Powder, Powder - Oral, Liquid - Oral, Cream, Topical, Cream - Topical, Liquid, Capsule, coated, Capsule, coated - Oral, Granule - Oral, Granule, Tablet, effervescent, Tablet, effervescent - Oral, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Kit, Lozenge, Lozenge - Oral, Powder - Topical, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Ophthalmic; Oral; Topical, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical
Chronic Fatigue Syndrome
65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL
, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer - Oral, Tablet, multilayer, Solution, Solution - Intravenous, Solution - Oral, Syrup, Syrup - Oral, Powder, Powder - Oral, Liquid - Oral, Cream, Topical, Cream - Topical, Liquid, Capsule, coated, Capsule, coated - Oral, Granule - Oral, Granule, Tablet, effervescent, Tablet, effervescent - Oral, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Kit, Lozenge, Lozenge - Oral, Powder - Topical, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Ophthalmic; Oral; Topical, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical
Muscle Pain
65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL
, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer - Oral, Tablet, multilayer, Solution, Solution - Intravenous, Solution - Oral, Syrup, Syrup - Oral, Powder, Powder - Oral, Liquid - Oral, Cream, Topical, Cream - Topical, Liquid, Capsule, coated, Capsule, coated - Oral, Granule - Oral, Granule, Tablet, effervescent, Tablet, effervescent - Oral, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Kit, Lozenge, Lozenge - Oral, Powder - Topical, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Ophthalmic; Oral; Topical, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical
Bronchopulmonary Dysplasia
65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL
, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer - Oral, Tablet, multilayer, Solution, Solution - Intravenous, Solution - Oral, Syrup, Syrup - Oral, Powder, Powder - Oral, Liquid - Oral, Cream, Topical, Cream - Topical, Liquid, Capsule, coated, Capsule, coated - Oral, Granule - Oral, Granule, Tablet, effervescent, Tablet, effervescent - Oral, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Kit, Lozenge, Lozenge - Oral, Powder - Topical, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Ophthalmic; Oral; Topical, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical
Chronic Pain
65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL
, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer - Oral, Tablet, multilayer, Solution, Solution - Intravenous, Solution - Oral, Syrup, Syrup - Oral, Powder, Powder - Oral, Liquid - Oral, Cream, Topical, Cream - Topical, Liquid, Capsule, coated, Capsule, coated - Oral, Granule - Oral, Granule, Tablet, effervescent, Tablet, effervescent - Oral, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Kit, Lozenge, Lozenge - Oral, Powder - Topical, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Ophthalmic; Oral; Topical, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical
Migraine
65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL
, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer - Oral, Tablet, multilayer, Solution, Solution - Intravenous, Solution - Oral, Syrup, Syrup - Oral, Powder, Powder - Oral, Liquid - Oral, Cream, Topical, Cream - Topical, Liquid, Capsule, coated, Capsule, coated - Oral, Granule - Oral, Granule, Tablet, effervescent, Tablet, effervescent - Oral, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Kit, Lozenge, Lozenge - Oral, Powder - Topical, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Ophthalmic; Oral; Topical, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical
Sleepiness
65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL
, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer - Oral, Tablet, multilayer, Solution, Solution - Intravenous, Solution - Oral, Syrup, Syrup - Oral, Powder, Powder - Oral, Liquid - Oral, Cream, Topical, Cream - Topical, Liquid, Capsule, coated, Capsule, coated - Oral, Granule - Oral, Granule, Tablet, effervescent, Tablet, effervescent - Oral, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Kit, Lozenge, Lozenge - Oral, Powder - Topical, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Ophthalmic; Oral; Topical, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical
Fever
65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL
, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer - Oral, Tablet, multilayer, Solution, Solution - Intravenous, Solution - Oral, Syrup, Syrup - Oral, Powder, Powder - Oral, Liquid - Oral, Cream, Topical, Cream - Topical, Liquid, Capsule, coated, Capsule, coated - Oral, Granule - Oral, Granule, Tablet, effervescent, Tablet, effervescent - Oral, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Kit, Lozenge, Lozenge - Oral, Powder - Topical, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Ophthalmic; Oral; Topical, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical
Influenza
65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL
, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer - Oral, Tablet, multilayer, Solution, Solution - Intravenous, Solution - Oral, Syrup, Syrup - Oral, Powder, Powder - Oral, Liquid - Oral, Cream, Topical, Cream - Topical, Liquid, Capsule, coated, Capsule, coated - Oral, Granule - Oral, Granule, Tablet, effervescent, Tablet, effervescent - Oral, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Kit, Lozenge, Lozenge - Oral, Powder - Topical, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Ophthalmic; Oral; Topical, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical
Antacid therapy
65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL
, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer - Oral, Tablet, multilayer, Solution, Solution - Intravenous, Solution - Oral, Syrup, Syrup - Oral, Powder, Powder - Oral, Liquid - Oral, Cream, Topical, Cream - Topical, Liquid, Capsule, coated, Capsule, coated - Oral, Granule - Oral, Granule, Tablet, effervescent, Tablet, effervescent - Oral, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Kit, Lozenge, Lozenge - Oral, Powder - Topical, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Ophthalmic; Oral; Topical, Kit - Oral; Respiratory (inhalation); Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical

Warnings

Caffeine Citrate has one contraindication, so it should not be consumed for the conditions listed in the following table.Caffeine Citrate Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Caffeine may interact with Pulse Frequency
There are 20 known major drug interactions with Caffeine Citrate.
Common Caffeine Citrate Drug Interactions
Drug Name
Risk Level
Description
Acenocoumarol
Major
The metabolism of Acenocoumarol can be decreased when combined with Caffeine.
Aminophylline
Major
The metabolism of Aminophylline can be decreased when combined with Caffeine.
Anagrelide
Major
The metabolism of Anagrelide can be decreased when combined with Caffeine.
Axitinib
Major
The metabolism of Axitinib can be decreased when combined with Caffeine.
Bendamustine
Major
The metabolism of Bendamustine can be decreased when combined with Caffeine.
Caffeine Citrate Toxicity & Overdose RiskThe lowest toxic dose of caffeine for rats is 192mg/kg. In humans, an acute fatal overdose is around 10-14 grams, which is equal to 150-200mg/kg of body weight. Signs of an overdose include nausea, vomiting, diarrhea, agitation, restlessness, insomnia, fast heartbeat, tremors, and in extreme cases, death. To treat an overdose, offer symptomatic treatment for mild cases and intubation and activated charcoal for severe cases. Benzodiazepines can be used to prevent or treat seizures, IV fluids and vasopressors can be used to combat hypotension, and magnesium and beta

Caffeine Citrate Novel Uses: Which Conditions Have a Clinical Trial Featuring Caffeine Citrate?

At present, 429 active studies are investigating the potential of Caffeine Citrate to relieve Chronic Fatigue Syndrome, Chronic Pain and Migraine.
Condition
Clinical Trials
Trial Phases
Influenza
29 Actively Recruiting
Not Applicable, Phase 4, Phase 2, Phase 1, Phase 3
Pain relief
15 Actively Recruiting
Early Phase 1, Not Applicable, Phase 4, Phase 2, Phase 1
Chronic Pain
129 Actively Recruiting
Not Applicable, Phase 4, Phase 2, Phase 3, Early Phase 1, Phase 1
Chronic Fatigue Syndrome
43 Actively Recruiting
Not Applicable, Phase 2, Phase 3, Phase 1, Phase 4
Indigestion
6 Actively Recruiting
Phase 3, Not Applicable, Phase 2
Respiratory Insufficiency
0 Actively Recruiting
Migraine
13 Actively Recruiting
Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4
Premature Birth
3 Actively Recruiting
Phase 3, Phase 2, Not Applicable
Catarrh
0 Actively Recruiting
Vascular Headaches
0 Actively Recruiting
Tension-Type Headache
0 Actively Recruiting
Athletic Performance
1 Actively Recruiting
Not Applicable
Eye
1 Actively Recruiting
Not Applicable
Toothache
0 Actively Recruiting
Muscle Pain
3 Actively Recruiting
Phase 4, Not Applicable, Phase 2
Sleepiness
5 Actively Recruiting
Not Applicable, Phase 3
Pain
0 Actively Recruiting
Fever
2 Actively Recruiting
Not Applicable, Phase 4
Mental Depression
0 Actively Recruiting
Pain management
0 Actively Recruiting

Patient Q&A Section about caffeine citrate

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is caffeine citrate the same as caffeine?

"The dose of caffeine base should be half the dose of caffeine citrate. Serum concentrations of caffeine may need to be monitored periodically to avoid toxicity."

Answered by AI

What are the common side effects of caffeine citrate?

"Notify your doctor if you experience any of the following side effects which may persist or worsen: nausea, vomiting, stomach upset, headache, trouble sleeping, restlessness, poor feeding, increased urination, rash or dry skin."

Answered by AI

What is caffeine citrate used for?

"Caffeine citrate injection is used to treat short-term apnea of prematurity in premature babies when their breathing centers are not fully developed."

Answered by AI

Can caffeine citrate be used in adults?

"The usual maintenance dose of caffeine citrate is 5 to 10 mg per kilogram of body weight per day, equivalent to 2.5 to 5 mg per kilogram of body weight per day of anhydrous caffeine base. Higher doses up to 20 mg per kilogram of body weight per day of caffeine citrate (equivalent to 10 mg per kilogram of body weight per day of anhydrous caffeine base) have occasionally been necessary. Treatment usually lasts for at least 48 hours."

Answered by AI

Clinical Trials for Caffeine Citrate

Image of BTT Medical Institute Aventura North in Miami, United States.

Niagen®Plus for Fatigue

18+
All Sexes
Miami, FL
The goal of this study is to learn about the safety of Niagen®Plus, an injectable form of nicotinamide riboside (NR), and to see how it affects levels of NAD+ in the blood. Niagen®Plus will be given either by subcutaneous (under the skin) or intramuscular (into the muscle) injection at two dose levels (50 mg or 100 mg). The main questions this study aims to answer are: Is Niagen®Plus safe and well-tolerated when given by injection several times over 100 days? How do NAD+ levels in blood change after repeated doses of Niagen®Plus? What are participants' and clinicians' experiences with the injections? Researchers will also look at changes in fatigue, sleep, quality of life, inflammation markers, mitochondrial efficiency, and perceived skin appearance. Participants will: Receive three injections in clinic on Days 1-3, followed by a Day 10 follow-up visit Self-inject Niagen®Plus at home three times per week from Days 10-100 Return to the clinic on Days 40 and 100 for safety and laboratory testing Complete short surveys about fatigue, sleep, and overall well-being throughout the study The study will include 40 generally healthy adults and will last about 100 days per participant.
Phase 1
Recruiting
BTT Medical Institute Aventura NorthChromaDex, Inc.
Image of McGill University Health Centre in Montreal, Canada.

Dexmedetomidine for Pain Relief

18 - 75
All Sexes
Montreal, Canada
This study will compare three different doses of perineural dexmedetomidine 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg as adjuvants to local anesthetics for ultrasound-guided infraclavicular brachial plexus blocks (ICBs). Our research hypothesis is that 1.33 mcg/kg will provide a 15%-longer duration than 1mcg/kg, which in turn will provide a 15%-longer duration than 0.67 mcg/kg. Since analgesic duration and sensory duration can be influenced by intake of pain medications and surgical trauma to small cutaneous nerves, respectively, we will select motor block duration as the main outcome to better target the action of dexmedetomidine on the brachial plexus.
Phase 2
Waitlist Available
McGill University Health CentreJulián Aliste, MD
Have you considered Caffeine Citrate clinical trials? We made a collection of clinical trials featuring Caffeine Citrate, we think they might fit your search criteria.Go to Trials
Image of Vanderbilt University Medical Center in Nashville, United States.

Lidocaine Infusions for Postoperative Pain

18+
All Sexes
Nashville, TN
The goal of this single-center, pragmatic, randomized, blinded, placebo-controlled trial is to evaluate the impact of intravenous (IV) lidocaine within the existing Enhanced Recovery After Surgery (ERAS)program on outcomes in patients after major abdominal surgery. The main questions the trial aims to answer are: The primary hypothesis is that utilization of IV lidocaine as part of a perioperative multimodal pain regimen will result in a reduction in hospital Case Mix Index-Adjusted Resource Length of Stay (CARLOS). The secondary hypotheses are that lidocaine infusion will result in a reduction in total inpatient opioid consumption (oral morphine milligram equivalents, oMMEs) and pain scores, and improved surgical outcomes (including return of bowel function, ileus, nausea, rapid responses called, surgical site infections, and ICU transfers), while also having minimal incidence of side effects (including double/blurry vision, tinnitus, sedation, and adverse events requiring early cessation).
Phase 4
Waitlist Available
Vanderbilt University Medical CenterDanial Shams, MD
Image of Baylor College of Medicine/Texas Children's Hospital in Austin, United States.

Guided Imagery Therapy for Abdominal Pain

7 - 12
All Sexes
Austin, TX
Chronic abdominal pain is common among children, and the majority of cases are attributed to functional abdominal pain disorders. One approach to treating these disorders is by using psychological therapies. This clinical trial aims to see how well pre-recorded guided imagery therapy sessions help children's abdominal pain when delivered via a mobile application (app) on a smartphone or tablet. Participants will complete a baseline abdominal pain and stooling diary to determine eligibility, as well as other surveys. Eligible participants will be given access to the guided imagery therapy mobile application. This intervention asks participants to listen to a 10- to 15-minute GIT session 5 out of 7 days per week for 8 weeks, in addition to their usual care for their abdominal pain. Then, participants will complete another abdominal pain and stooling diary, along with other psychometric surveys, at the end of this intervention period. Participants will also collect another diary and surveys 3 months post-treatment.
Waitlist Available
Has No Placebo
Baylor College of Medicine/Texas Children's Hospital (+1 Sites)
Image of National Institutes of Health Clinical Center in Bethesda, United States.

BPL-1357 for Flu

18 - 55
All Sexes
Bethesda, MD
Background: Influenza (flu) infections are a serious global health threat. Each year, between 3 and 5 million people get the flu, and up to 500,000 die from it. Current vaccines protect against seasonal flus, but broader vaccines are needed to protect against potential flu pandemics. Objective: To test an experimental flu vaccine. Eligibility: Healthy people aged 18 to 55 years. Design: The study will last 5 to 8 months and has 2 phases, A and B. The study vaccine will be given either as a shot in the arm or as a nasal spray. Participants will receive 1 of 3 combinations: (1) study vaccine in the nose and placebo in the arm; (2) placebo in the nose and study vaccine in the arm; or (3) placebo in the nose and placebo in the arm. A placebo is just like the real vaccine but contains no active ingredients. Phase A: Participants will have 5 clinic visits over 56 days. They will receive a shot and a nasal spray at 2 of the visits, 28 days apart. At each visit, they will have a physical exam, with tests of their blood, urine, and nasal secretions. They will check their temperature at home and record any symptoms for 7 days after each vaccine. Phase B: Participants will stay in the hospital for at least 9 days. They will be infected with a flu virus. They will provide blood, urine, and nasal fluid samples. They will have tests of their heart function. They will remain in the hospital until they test negative for the flu 2 days in a row. They will have 2 follow-up visits, 4 and 8 weeks after leaving the hospital.
Phase 2
Waitlist Available
National Institutes of Health Clinical Center (+1 Sites)Luca T Giurgea, M.D.
Image of Vanderbilt University Medical Center in Nashville, United States.

High vs. Standard Dose Influenza Vaccines for Flu

18+
All Sexes
Nashville, TN
This will be a follow-up study to the "Comparison of High Dose vs. Standard Dose Influenza Vaccine in Lung Allograft Recipient" study (DMID Protocol Number 22-0014) at Vanderbilt University Medical Center. Lung transplantation is a life-saving therapy for patients with advanced lung disease, and is also associated with an improvement in quality of life. However, due to the need for life-long immunosuppression to prevent acute cellular rejection and chronic lung allograft dysfunction ("chronic rejection"), lung transplant recipients are at risk for developing major infections. In fact, one-year survival is 85%, with infection being the leading cause of death within the first year post-transplant. We will conduct a follow-up phase II, randomized, double-blind trial to assess the impact of subsequent administration of two doses of HD-IIV compared to two doses of SD-IIV among lung recipients during the early post-transplant period. Demonstration of improved immunogenicity from two doses of HD-IIV over consecutive influenza seasons would provide potential broad benefit in reducing influenza disease and its associated complications in lung transplant recipients. Moreover, studying vaccine immunogenicity and safety in the same participants over consecutive years can provide insight into the influence of immunosuppression levels and allograft aging on vaccine-mediated immune modulation. This proposed study design will contribute significantly to influenza vaccination guidance and policy for the highly vulnerable lung transplant population. This proposed study is designed to address several key knowledge gaps in vaccine-mediated protection of lung transplant recipients against influenza: * Is there increased immunogenicity with administration of one or two doses of HD-IIV or SD-IIV in the subsequent season compared to two doses of HD-IIV or SD-IIV in the first season? * What is the durability of the humoral and cellular immune response between influenza seasons and does two doses of HD-IIV or SD-IIV sustain higher HAI titers compared to two doses of HD-IIV or SD-IIV in the first season? * What is the impact of maintenance immunosuppression levels on influenza vaccine immunogenicity within the same participant? * Will the optimal immunogenic vaccination strategy be associated with an acceptable long-term safety profile over successive influenza seasons, including injection-site and systemic reactions, allosensitization, and organ rejection?
Phase 2
Recruiting
Vanderbilt University Medical CenterNatahsa Halasa, MD, MPH
Have you considered Caffeine Citrate clinical trials? We made a collection of clinical trials featuring Caffeine Citrate, we think they might fit your search criteria.Go to Trials
Image of University Hospitals Cleveland Medical Center in Cleveland, United States.

Erector Spinae Plane Block for Pain

21 - 75
All Sexes
Cleveland, OH
As per usual care for spine surgery, participants will have their back cleaned with alcohol and a needle will be placed using ultrasound for the ESP block. Through the needle, a small catheter will be placed in the participants back and the needle removed. Approximately one hour prior to the start of surgery, a numbing medication (ropivacaine, similar to Novocaine) in combination with dexmedetomidine (a pain medicine that is used in nerve block and that is not a narcotic) and contrast dye (iohexol) will be injected through the catheter. Participants will then go through the QST procedure (test of buzzing sensation and temperature sensation through pads applied to their skin) to assess the numb areas and then head to the operating room. In the operating room, the catheter will be removed after the surgeon obtains baseline CT scan images of the spine. Once surgery is completed, investigators will record pain scores over the next four days in the hospital and the amount of pain medication needed for controlling pain related to the surgery.
Recruiting
Has No Placebo
University Hospitals Cleveland Medical CenterSalim Hayek, MD
Image of Altasciences Inc - Kansas City in Overland Park, United States.

VNT-101 for Safety and Tolerability Study

18 - 59
All Sexes
Overland Park, KS
A randomized, double-blind, placebo-controlled Phase 1 study conducted at a single center with approximately 78 healthy adults aged 18-59 years. Part 1 Single Ascending Dose (SAD) will enroll 48 participants into six cohorts (S1-S6) to receive single oral doses of VNT-101 (100-1500 mg) or placebo under fasting or fed (S5 only) conditions. Part 2 Multiple Ascending Dose (MAD) will enroll 30 participants into three cohorts (M1-M3) to receive multiple oral doses of VNT-101 (250-750 mg BID Days 1-5, QD Day 6) or placebo under fasting conditions. Dose escalation in both parts will proceed after Protocol Safety Review Team (PSRT) review. The primary objective for Part 1 is to evaluate the safety and tolerability of single ascending oral (SAD) doses of VNT-101 in healthy adult participants under either fasting or fed conditions. The primary objective for part 2 is to evaluate the safety and tolerability of multiple ascending oral (MAD) doses of VNT-101 in healthy adult participants.
Phase 1
Recruiting
Altasciences Inc - Kansas City
Have you considered Caffeine Citrate clinical trials? We made a collection of clinical trials featuring Caffeine Citrate, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security